Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析

◆英語タイトル:Herantis Pharma Plc (HRTIS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14989
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company’s pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfactin recovers the damaged lymph system by reconstituting lymphatic vasculature. Herantis Pharma offers CDNF for disease modification in neurodegenerative diseases such as Parkinson’s and ALS. The company develops drug candidates through late pre-clinical and early clinical stages. It partners with pharmaceutical and biotech companies. Herantis Pharma is headquartered in Espoo, Finland.

Herantis Pharma Plc Key Recent Developments

Feb 28,2019: Herantis Pharma financial statements release January 1 – December 31, 2018
Feb 15,2019: Notice to convene Herantis Pharma Plc”s Extraordinary General Meeting of shareholders Notice to convene Herantis Pharma Plc”s Extraordinary General Meeting of shareholders Herantis Pharma Plc Company release 15 February 2019 at… Read More
Aug 29,2018: Herantis Pharma’s half year financial report January 1 – June 30, 2018
Jul 09,2018: Herantis Pharma to develop non-invasive CDNF for Parkinson’s

This comprehensive SWOT profile of Herantis Pharma Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Herantis Pharma Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Herantis Pharma Plc – Key Information
Herantis Pharma Plc – Overview
Herantis Pharma Plc – Key Employees
Herantis Pharma Plc – Key Employee Biographies
Herantis Pharma Plc – Key Operational Heads
Herantis Pharma Plc – Major Products and Services
Herantis Pharma Plc – History
Herantis Pharma Plc – Company Statement
Herantis Pharma Plc – Locations And Subsidiaries
Herantis Pharma Plc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Herantis Pharma Plc – Business Description
Herantis Pharma Plc – Corporate Strategy
Herantis Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Herantis Pharma Plc – Strengths
Herantis Pharma Plc – Weaknesses
Herantis Pharma Plc – Opportunities
Herantis Pharma Plc – Threats
Herantis Pharma Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Herantis Pharma Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Herantis Pharma Plc, Key Information
Herantis Pharma Plc, Key Ratios
Herantis Pharma Plc, Share Data
Herantis Pharma Plc, Major Products and Services
Herantis Pharma Plc, History
Herantis Pharma Plc, Key Employees
Herantis Pharma Plc, Key Employee Biographies
Herantis Pharma Plc, Key Operational Heads
Herantis Pharma Plc, Other Locations
Herantis Pharma Plc, Subsidiaries
Herantis Pharma Plc, Key Manufacturing facilities
Herantis Pharma Plc, Key Competitors
Herantis Pharma Plc, SWOT Analysis
Herantis Pharma Plc, Ratios based on current share price
Herantis Pharma Plc, Annual Ratios
Herantis Pharma Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Herantis Pharma Plc, Performance Chart
Herantis Pharma Plc, Ratio Charts

★海外企業調査レポート[Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nido Petroleum Ltd:企業の戦略的SWOT分析
    Nido Petroleum Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Shoal Point Energy Ltd (SHP):石油・ガス:M&Aディール及び事業提携情報
    Summary Shoal Point Energy Ltd (Shoal Point Energy) is an oil and gas exploration and development company that acquires, develops, explores, and produces petroleum products. The company holds interests in Green Point Oil-in-Shale and Humber Arm Shale project. It also holds interests in the explorati …
  • Stock Spirits Group PLC:企業の戦略・SWOT・財務分析
    Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report Summary Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Energy XXI Gulf Coast Inc (EGC):石油・ガス:M&Aディール及び事業提携情報
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Bemis Company Inc (BMS):企業の財務・戦略的SWOT分析
    Bemis Company Inc (BMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野:企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • Airgas Inc-医療機器分野:企業M&A・提携分析
    Summary Airgas Inc (Airgas), a subsidiary of Air Liquide S.A., is a supplier of industrial, medical, specialty gases and related equipment. The company also provides welding equipment, safety products, ammonia products, refrigerants, nitrous oxide, atmospheric gases, carbon dioxide and dry ice, weld …
  • Spanish National Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that offers cancer research programs. The center is an integral cancer research institute which integrates basic and translational cancer research. It conducts various scientific programs which include molecular onco …
  • TaiMed Biologics Inc (4147):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiMed Biologics Inc (TMB) is a biotechnology company that provides novel medicines for the prevention and treatment of viral infectious diseases. The company provides pipeline products such as TMB-355, TMB-607 and TMB-571, among others. It offers TMB-355 which is a proprietary humanized ant …
  • Asda Stores Ltd:戦略・SWOT・企業財務分析
    Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Callon Petroleum Co (CPE):企業の財務・戦略的SWOT分析
    Summary Callon Petroleum Co (CPC) is an oil and gas company that offers building reserves and production of onshore and offshore oil and natural gas. The company carries out acquisition, development, exploration, and exploitation of unconventional onshore, oil, and natural gas reserves. It operates …
  • NextPharma Technologies Holding Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary NextPharma Technologies Holding Ltd (NextPharma) is a contract development and manufacturing organization that provides pharmaceutical products and services. The company offers wide range of services such as pharmaceutical development, analytical services, clinical trials services, commercia …
  • CSL Ltd (CSL):医療機器:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • GenMark Diagnostics Inc (GNMK):企業の財務・戦略的SWOT分析
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • Barrick Gold Corporation:企業のM&A・事業提携・投資動向
    Barrick Gold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Barrick Gold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Givaudan SA:戦略・SWOT・企業財務分析
    Givaudan SA - Strategy, SWOT and Corporate Finance Report Summary Givaudan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Cargolux Airlines International S.A.:企業の戦略・SWOT・財務分析
    Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report Summary Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Pfizer Inc (PFE)-製薬・医療分野:企業M&A・提携分析
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • Sao Martinho SA (SMTO3):企業の財務・戦略的SWOT分析
    Sao Martinho SA (SMTO3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆